Informatie:
Fout:
ID
45582
Beschrijving
Principal Investigator: Charles Perou, PhD, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill,Chapel Hill, NC, USA MeSH: Breast Neoplasms https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000676 The goal of this study is to study gene expression patterns in tumors, normal tissues, and cell lines.
Link
Trefwoorden
Versies (1)
- 25-01-23 25-01-23 - Chiara Middel
Houder van rechten
Charles Perou, PhD, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill,Chapel Hill, NC, USA
Geüploaded op
25 januari 2023
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
dbGaP phs000676 Sequence-Based Analysis of Human Breast Tumors
Subject ID, affection status, and consent group of participants with breast cancer and involved in the "Sequence-Based Analysis of Human Breast Tumors" project.
- StudyEvent: SEV1
- Subject ID, affection status, and consent group of participants with breast cancer and involved in the "Sequence-Based Analysis of Human Breast Tumors" project.
- Subject ID, sample ID, and sample use variable of participants with breast cancer and involved in the "Sequence-Based Analysis of Human Breast Tumors" project.
- Subject ID, age, race, survival event, tumor characteristics including ER, PR, HER2 status, and PAM50 subtype, tumor size, grade, M stage, and nodule status of participants with breast cancer and involved in the "Sequence-Based Analysis of Human Breast Tumors" project.
- Sample ID and GEO accession ID of samples obtained from participants with breast cancer and involved in the "Sequence-Based Analysis of Human Breast Tumors" project.
- Sample ID, analyte type, body site where sample was obtained, protocols to extract total RNA, cell or tissue type of sample, tumor status of sample, protocols to remove rRNA from sequencing library, primary tumor, metastasis, or transformed cell line, primary tumor location, sequencing center, tissue type to extract total RNA for library construction, tumor grade, tumor stage, and tumor treatment of participants with breast cancer and involved in the "Sequence-Based Analysis of Human Breast Tumors" project.
Similar models
Subject ID, affection status, and consent group of participants with breast cancer and involved in the "Sequence-Based Analysis of Human Breast Tumors" project.
- StudyEvent: SEV1
- Subject ID, affection status, and consent group of participants with breast cancer and involved in the "Sequence-Based Analysis of Human Breast Tumors" project.
- Subject ID, sample ID, and sample use variable of participants with breast cancer and involved in the "Sequence-Based Analysis of Human Breast Tumors" project.
- Subject ID, age, race, survival event, tumor characteristics including ER, PR, HER2 status, and PAM50 subtype, tumor size, grade, M stage, and nodule status of participants with breast cancer and involved in the "Sequence-Based Analysis of Human Breast Tumors" project.
- Sample ID and GEO accession ID of samples obtained from participants with breast cancer and involved in the "Sequence-Based Analysis of Human Breast Tumors" project.
- Sample ID, analyte type, body site where sample was obtained, protocols to extract total RNA, cell or tissue type of sample, tumor status of sample, protocols to remove rRNA from sequencing library, primary tumor, metastasis, or transformed cell line, primary tumor location, sequencing center, tissue type to extract total RNA for library construction, tumor grade, tumor stage, and tumor treatment of participants with breast cancer and involved in the "Sequence-Based Analysis of Human Breast Tumors" project.
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
SUBJECT_ID
Item
Subject ID
string
C2348585 (UMLS CUI [1,1])
Item
Consent group as determined by DAC
text
C0021430 (UMLS CUI [1,1])
C0441833 (UMLS CUI [1,2])
C0441833 (UMLS CUI [1,2])
CL Item
General Research Use (MDS) (GRU-MDS) (1)
C0021430 (UMLS CUI [1,1])
C0242481 (UMLS CUI [1,2])
C0242481 (UMLS CUI [1,2])
CL Item
Disease-Specific (Cancer, MDS) (DS-CA-MDS) (2)
CL Item
Control (1)
C3274648 (UMLS CUI [1,1])
CL Item
Case (2)
C3274647 (UMLS CUI [1,1])
CL Item
Other (3)